Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010
Grewal et al1 should be congratulated for their recent study concerning the use of 3% hypertonic saline in the treatment of bronchiolitis. It is refreshing to see such a well-conducted pediatric trial based in the emergency department (ED). We would, however, make several points regarding the methodology of the study and raise concerns about the ultimate message. We believe that the efficacy of the treatment must be looked at in the wider context of the patient journey.
Horner D, Bartram T, Jenner R, Morton R. Can the Efficacy of Hypertonic Saline in Bronchiolitis Truly Be Assessed With a Short-term Primary Outcome?. Arch Pediatr Adolesc Med. 2010;164(4):395. doi:10.1001/archpediatrics.2010.36